2,050 Shares in DaVita Inc. (NYSE:DVA) Bought by Asahi Life Asset Management CO. LTD.

Asahi Life Asset Management CO. LTD. bought a new stake in DaVita Inc. (NYSE:DVA) in the fourth quarter, HoldingsChannel reports. The fund bought 2,050 shares of the company’s stock, valued at approximately $307,000.

A number of other hedge funds have also added to or reduced their stakes in the business. MML Investors Services LLC grew its position in DaVita by 1.3% in the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after purchasing an additional 68 shares in the last quarter. Exchange Traded Concepts LLC grew its position in DaVita by 8.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after purchasing an additional 68 shares in the last quarter. Impact Partnership Wealth LLC grew its position in DaVita by 3.7% in the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after purchasing an additional 70 shares in the last quarter. Contravisory Investment Management Inc. grew its position in DaVita by 1.2% in the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after purchasing an additional 73 shares in the last quarter. Finally, First Trust Direct Indexing L.P. grew its position in DaVita by 2.9% in the third quarter. First Trust Direct Indexing L.P. now owns 3,051 shares of the company’s stock valued at $500,000 after purchasing an additional 86 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of DVA opened at $147.83 on Monday. The firm has a 50-day moving average of $160.66 and a 200-day moving average of $158.23. DaVita Inc. has a one year low of $124.70 and a one year high of $179.60. The company has a market cap of $11.83 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 1.07 and a beta of 0.94. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21.

DaVita (NYSE:DVA) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on DVA. Cowen reaffirmed a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Barclays lifted their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.